Evolution of the Average Target: AstraZeneca PLC

Evolution of the Average Target - AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Evolution of the Target Price - AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

7e292da4b6.yd3wIaKo1HJH7jWYykGAH2CBGRSjtFuM3LM2D0CnD1E.o5OCVMzq50EBvVD9-jDkfjPDK3_292L05d9HRnPTZCefiKhO9ZmGBxavcA~fceac42d00d9ae167a3f9148b66bf0d2
13/11 Sanofi extends its winning streak, Citi raises target Zonebourse
09/11 AstraZeneca PLC : Deutsche Bank remains Neutral ZD
09/11 Berenberg raises Autotrader and likes Rightmove AN
05/11 AstraZeneca PLC : Jefferies reiterates its Buy rating ZD
04/11 Jefferies cuts Haleon; LBBW raises Shell target AN
03/11 AstraZeneca PLC : DZ Bank keeps its Buy rating ZD
03/11 Bernstein Lifts AstraZeneca PT, Affirms Outperform Rating MT
03/11 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
03/11 AstraZeneca PLC : Goldman Sachs reiterates its Buy rating ZD
03/11 AstraZeneca PLC : Bernstein reiterates its Buy rating ZD
03/11 Jefferies raises Centrica; Davy cuts Vistry AN
03/11 Jefferies raises Centrica; Davy cuts Vistry AN
02/11 AstraZeneca PLC : UBS reiterates its Buy rating ZD
02/11 AstraZeneca PLC : Barclays keeps its Buy rating ZD
02/11 AlphaValue/Baader Europe Downgrades AstraZeneca to Reduce MT
02/11 RBC Raises Price Target on AstraZeneca to GBP152.50 From GBP145, Keeps Outperform Rating MT
02/11 AstraZeneca PLC : Deutsche Bank reaffirms its Neutral rating ZD
02/11 Berenberg cuts Haleon, Barclays cuts Dr Martens AN
02/11 AstraZeneca PLC : Buy rating from RBC ZD
30/10 AstraZeneca: Q3 reassures investors, but valuation lacks a safety net Alphavalue
30/10 AstraZeneca Kept at Buy as BofA Notes Q3 Results, 'Very Busy' Pipeline MT
30/10 AstraZeneca PLC : UBS reiterates its Buy rating ZD
30/10 AstraZeneca PLC : Buy rating from Jefferies ZD
30/10 AstraZeneca PLC : Receives a Buy rating from Bernstein ZD
28/10 AstraZeneca PLC : Deutsche Bank remains Neutral ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.44%
+2.58%
-1.11%
+6.64%
-3.15%
+11.81%
-4.82%
-6.38%
+4.98%
+5.14%
Average +3.21%
Weighted average by Cap. +2.83%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
185.09USD
Average target price
215.52USD
Spread / Average Target
+16.44%
High Price Target
275.05USD
Spread / Highest target
+48.60%
Low Price Target
160.37USD
Spread / Lowest Target
-13.36%

Analyst Consensus Detail

Analyst consensus - AstraZeneca PLC

Consensus revision (last 18 months)

Consensus revision (last 18 months) - AstraZeneca PLC
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AstraZeneca PLC
  1. Stock Market
  2. Stocks
  3. AZN Stock
  4. Consensus AstraZeneca PLC